Source:http://linkedlifedata.com/resource/pubmed/id/10021935
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
2
|
pubmed:dateCreated |
1999-5-11
|
pubmed:abstractText |
Cyclization of 8-bromo-9-alkylaminoethyl-adenine quantitatively affords a substituted imidazo[1,2-e]purine. The corresponding heterodimer, imidazo[1,2-e]purine-acridine, was prepared and its interaction with abasic site containing oligonucleotides was studied.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Jan
|
pubmed:issn |
0960-894X
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
18
|
pubmed:volume |
9
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
233-6
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading | |
pubmed:year |
1999
|
pubmed:articleTitle |
Synthesis of an imidazo[1,2-e]purine-acridine heterodimer for targeting abasic sites in DNA.
|
pubmed:affiliation |
LEDSS, UMR CNRS 5616/Université J. Fourier, Grenoble, France.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|